<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02330120</url>
  </required_header>
  <id_info>
    <org_study_id>intensive care</org_study_id>
    <nct_id>NCT02330120</nct_id>
  </id_info>
  <brief_title>Effects of Dexmedetomidine and Propofol on Pulmonary Mechanics</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the effects of dexmedetomidine and propofol on pulmonary
      mechanics in intensive care patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to compare the effects propofol and dexmedetomidine on pulmonary
      mechanics. Sixty patients mechanically ventilated in intensive care unit are included in this
      study. Patients are divided into two random groups, Group P (propofol) and Group D
      (dexmedetomidine). Propofol infusion 0.5-2 mg/kg/h is given to Group P patients and
      dexmedetomidine infusion 0.2-0.7 mcg/kg/h is given to Group D patients for sedation. Initial
      blood gas analysis, airway resistance (cmH2O/L/sec), positive end-expiratory pressure (PEEP,
      cmH20), frequency (breath/min), tidal volume (mL/min), minute volume (mL), peak airway
      pressure (cmH20), compliance (mL/cmH20), endtidal CO2 (mmHg), SvO2 (%) values are recorded.
      This parameters are evaluated with Drager Evita 4 ventilator and recorded on
      5th,15th,30th,45th ve 60th minutes . Sedation is observed using Riker and Ramsey
      Sedation-Agitation Scale. Compliance of patients to mechanical ventilation is observed and
      recorded.

      The primary outcome measures are airway resistance and peak airway pressure. Secondary
      outcome measure is sedation score.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>airway resistance</measure>
    <time_frame>60 minutes</time_frame>
    <description>airway resistans measured by Evita 4 ventilator flow sensor</description>
  </primary_outcome>
  <primary_outcome>
    <measure>peak airway pressure values</measure>
    <time_frame>60 minutes</time_frame>
    <description>peak airway pressure values provide the methods used to Evita 4 ventilator flow sensor</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Abnormal Respiratory Airway Resistance</condition>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol infusion 0.5-2 mg/kg/h for sedation in mechanically ventilated patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexmedetomidine infusion 0.2-0.7 mcg/kg/h for sedation in mechanically ventilated patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine</intervention_name>
    <arm_group_label>dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients mechanically ventilated in intensive care unit

        Exclusion Criteria:

          -  Patients with contraindications for using propofol and dexmedetomidine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cukurova University</name>
      <address>
        <city>Adana</city>
        <zip>01130</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Fernandes FC, Ferreira HC, Cagido VR, Carvalho GM, Pereira LS, Faffe DS, Zin WA, Rocco PR. Effects of dexmedetomidine on respiratory mechanics and control of breathing in normal rats. Respir Physiol Neurobiol. 2006 Dec;154(3):342-50. Epub 2006 Mar 9.</citation>
    <PMID>16527548</PMID>
  </reference>
  <reference>
    <citation>Bang SR, Lee SE, Ahn HJ, Kim JA, Shin BS, Roe HJ, Sim WS. Comparison of respiratory mechanics between sevoflurane and propofol-remifentanil anesthesia for laparoscopic colectomy. Korean J Anesthesiol. 2014 Feb;66(2):131-5. doi: 10.4097/kjae.2014.66.2.131. Epub 2014 Feb 28.</citation>
    <PMID>24624271</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2014</study_first_submitted>
  <study_first_submitted_qc>December 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2015</study_first_posted>
  <last_update_submitted>December 9, 2015</last_update_submitted>
  <last_update_submitted_qc>December 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>mediha turktan</investigator_full_name>
    <investigator_title>Cukurova University</investigator_title>
  </responsible_party>
  <keyword>peak airway pressure</keyword>
  <keyword>airway resistance</keyword>
  <keyword>sedation</keyword>
  <keyword>intensive care</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

